In Vitro and in Vivo Anti-Tumor Effects of Brexpiprazole, a Newly-Developed Serotonin-Dopamine Activity Modulator With an Improved Safety Profile

Oncotarget - United States
doi 10.18632/oncotarget.26949
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

Impact Journals, LLC


Related search